8 Results for "

ACSL1

" in MedChemExpress (MCE) Product Catalog:
Products (8)

8 Results for "ACSL1" in MCE Product Catalog:

1
1 Cited Publications
Cat. No.: HY-N0723
CAS No.: 64809-67-2
Neomangiferin is an orally active natural flavonoid. Neomangiferin partially ameliorates non-alcoholic fatty liver disease (NAFLD) by regulating the expression of genes related to free fatty acid uptake and lipid oxidation. Neomangiferin exerts anti-colitis effects by inhibiting Th17/Treg cell differentiation. Neomangiferin exerts anti-aging and lifespan-extending effects by targeting upregulation of bas-1, which in turn activates the autophagy, IIS and MAPK pathways. Neomangiferin has the potential to prevent aseptic loosening of prostheses after total joint arthroplasty due to its significant anti-inflammatory and osteoclastogenesis-inhibiting effects [1] .
loading...
    loading...
Cat. No.: HY-RS00200
Research Areas:  

Others

ACSL1 Human Pre-designed siRNA Set A contains three designed siRNAs for ACSL1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

loading...
    loading...
Cat. No.: HY-RS16255
Research Areas:  

Others

Acsl1 Mouse Pre-designed siRNA Set A contains three designed siRNAs for Acsl1 gene (Mouse), as well as a negative control, a positive control, and a FAM-labeled negative control.
loading...
    loading...
Cat. No.: HY-RS24003
Research Areas:  

Others

Acsl1 Rat Pre-designed siRNA Set A contains three designed siRNAs for Acsl1 gene (Rat), as well as a negative control, a positive control, and a FAM-labeled negative control.

loading...
    loading...
Cat. No.: HY-186095
Target:  

ACSL Family

Research Areas:  

Metabolic Disease

LP-911888 is an orally active ACSL5/ACSL1 inhibitor, with IC50 values of 1 nM and 3 nM against mouse and human ACSL5, and IC50 values of 2 nM and 9 nM against mouse and human ACSL1, respectively. LP-911888 inhibits intestinal triglyceride uptake; it also reduces body weight and food consumption in diet-induced obese mice, and delays gastric emptying by activating the ileal brake pathway. LP-911888 can be used in studies of diet-induced obesity [1].
loading...
    loading...
Cat. No.: HY-186096
Research Areas:  

Metabolic Disease

LP-856866 is an orally active ACSL5 inhibitor, with IC50 values of 8 nM and 4 nM against mouse and human ACSL5, respectively, and IC50 values of 6 nM and 17 nM against mouse and human ACSL1, respectively. LP-856866 induces delayed gastric emptying, promotes GLP-1 release, reduces food intake, decreases body weight and body fat mass, preserves lean body mass, improves glucose homeostasis, enhances insulin sensitivity, reduces hepatic lipid accumulation, and lowers serum triglyceride and total cholesterol levels. LP-856866 is applicable to research on diet-induced obesity [1].
loading...
    loading...
Cat. No.: HY-P87353
Synonyms: ACS 1 antibody; ACS1 antibody; ACSL 1 antibody; ACSL1 antibody; ACSL1_HUMAN antibody; Acyl CoA synthetase 1 antibody; Acyl CoA synthetase long chain family member 1 antibody; Acyl-CoA synthetase 1 antibody; FACL 1 antibody; FACL 2 antibody

Host:  

Mouse

Application:  

WB, IHC-P

Reactivity:  

Human, Mouse, Rat

loading...
    loading...
Cat. No.: HY-P704210
Purity:  ≥ 90%, as determined by reducing SDS-PAGE.
Synonyms: Acyl-CoA synthetase 1; ACS1; Arachidonate--CoA ligase; Long-chain acyl-CoA synthetase 1; LACS 1; Long-chain acyl-CoA synthetase 2; LACS 2; Long-chain fatty acid-CoA ligase 2; Palmitoyl-CoA ligase 1; Palmitoyl-CoA ligase 2; Phytanate--CoA ligase
Species:  
Source:  
loading...
    loading...